{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:15:06Z","timestamp":1761898506310,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.clinre.2018.01.004","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:26:02Z","timestamp":1521159962000},"page":"505-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Why and when to measure ammonemia in cirrhosis?"],"prefix":"10.1016","volume":"42","author":[{"given":"Maxime","family":"Mallet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Thabut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9155-3345","authenticated-orcid":false,"given":"Marika","family":"Rudler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.clinre.2018.01.004_bib0005","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jceh.2014.12.005","article-title":"Hepatic encephalopathy: historical remarks","volume":"5","author":"Amodio","year":"2015","journal-title":"J Clin Exp Hepatol"},{"issue":"6869","key":"10.1016\/j.clinre.2018.01.004_bib0010","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(55)90422-0","article-title":"Blood-ammonium levels in liver disease and hepatic coma","volume":"268","author":"Phear","year":"1955","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clinre.2018.01.004_bib0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11011-008-9124-3","article-title":"Gut ammonia production and its modulation","volume":"24","author":"Romero-Gomez","year":"2009","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.clinre.2018.01.004_bib0020","article-title":"Understanding hepatic encephalopathy","author":"Weiss","year":"2017","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.clinre.2018.01.004_bib0025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.nurt.2010.05.015","article-title":"Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy","volume":"7","author":"Brusilow","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.clinre.2018.01.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-017-9812-3","article-title":"Hepatic encephalopathy: a critical current review","author":"Hadjihambi","year":"2018","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.clinre.2018.01.004_bib0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11011-012-9351-5","article-title":"Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy","volume":"28","author":"Bosoi","year":"2013","journal-title":"Metab Brain Dis"},{"issue":"3","key":"10.1016\/j.clinre.2018.01.004_bib0040","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/hep.23367","article-title":"Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis","volume":"51","author":"Shawcross","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clinre.2018.01.004_bib0045","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.28696","article-title":"Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice","volume":"64","author":"Kang","year":"2016","journal-title":"Hepatology"},{"issue":"3\u20134","key":"10.1016\/j.clinre.2018.01.004_bib0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11011-007-9069-y","article-title":"The anaplerotic flux and ammonia detoxification in hepatic encephalopathy","volume":"22","author":"Zwingmann","year":"2007","journal-title":"Metab Brain Dis"},{"issue":"4","key":"10.1016\/j.clinre.2018.01.004_bib0055","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/hep.29031","article-title":"Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease","volume":"65","author":"Hadjihambi","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2018.01.004_bib0060","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2014.05.042","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver, Diseases","volume":"61","year":"2014","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2018.01.004_bib0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/hep.510310107","article-title":"Partial pressure of ammonia versus ammonia in hepatic encephalopathy","volume":"31","author":"Kramer","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clinre.2018.01.004_bib0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0168-8278(02)00436-1","article-title":"Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy","volume":"38","author":"Nicolao","year":"2003","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2018.01.004_bib0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01477-8","article-title":"Correlation between ammonia levels and the severity of hepatic encephalopathy","volume":"114","author":"Ong","year":"2003","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.clinre.2018.01.004_bib0080","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1046\/j.1440-1681.2000.03312.x","article-title":"Ammonia response to constant exercise: differences to the lactate response","volume":"27","author":"Ogino","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"14","key":"10.1016\/j.clinre.2018.01.004_bib0085","doi-asserted-by":"crossref","first-page":"667","DOI":"10.4254\/wjh.v9.i14.667","article-title":"Protein tolerance to standard and high protein meals in patients with liver cirrhosis","volume":"9","author":"Campollo","year":"2017","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2018.01.004_bib0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.gastro.2016.09.007","article-title":"Proton pump inhibitors increase risk for hepatic encephalopathy in patients with cirrhosis in a population study","volume":"152","author":"Tsai","year":"2017","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.clinre.2018.01.004_bib0095","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jhep.2016.07.046","article-title":"Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy","volume":"65","author":"Weiss","year":"2016","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.clinre.2018.01.004_bib0100","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1053\/j.gastro.2016.10.049","article-title":"Proton pump inhibitor administration triggers encephalopathy in cirrhotic patients by modulating blood-brain barrier drug transport","volume":"152","author":"Assaraf","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.clinre.2018.01.004_bib0105","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/hep.510240316","article-title":"The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis","volume":"24","author":"Quero","year":"1996","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinre.2018.01.004_bib0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2013.10.004","article-title":"Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)","volume":"60","author":"Cordoba","year":"2014","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.clinre.2018.01.004_bib0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MCG.0000000000000443","article-title":"Serum ammonia in associated with transplant-free survival in hospitalized patients with acutely decompensated cirrhosis","volume":"50","author":"Patwardhan","year":"2016","journal-title":"J Cin Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2018.01.004_bib0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11011-016-9938-3","article-title":"Ammonia toxicity: from head to toe?","volume":"32","author":"Dasarathy","year":"2017","journal-title":"Metab Brain Dis"},{"issue":"4","key":"10.1016\/j.clinre.2018.01.004_bib0125","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jhep.2015.11.019","article-title":"Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension","volume":"64","author":"Jalan","year":"2016","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2018.01.004_bib0130","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cgh.2015.11.018","article-title":"Fasting blood ammonia predicts risk and frequency of hepatic encephalopathy episodes in patients with cirrhosis","volume":"14","author":"Vierling","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2018.01.004_bib0135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11011-013-9391-5","article-title":"Ornithine phenylacetate revisited","volume":"28","author":"Jover-Cobos","year":"2013","journal-title":"Metab Brain Dis"},{"issue":"4","key":"10.1016\/j.clinre.2018.01.004_bib0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM197007232830401","article-title":"Ammonia production in the human colon. Effects of cleansing, neomycin and acetohydroxamic acid","volume":"283","author":"Wolpert","year":"1970","journal-title":"New Eng J Med"},{"key":"10.1016\/j.clinre.2018.01.004_bib0145","first-page":"Cd003044","article-title":"Non-absorbable disaccharides versus placebo\/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis","volume":"5","author":"Gluud","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.clinre.2018.01.004_bib0150","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1185\/03007999709113333","article-title":"Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trial","volume":"13","author":"Miglio","year":"1997","journal-title":"Curr Med Rese Opin"},{"issue":"5","key":"10.1016\/j.clinre.2018.01.004_bib0155","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jgh.12142","article-title":"l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials","volume":"28","author":"Bai","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2018.01.004_bib0160","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/hep.21930","article-title":"Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis","volume":"46","author":"Hassanein","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clinre.2018.01.004_bib0165","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/hep.26314","article-title":"Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy","volume":"57","author":"Laleman","year":"2013","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.clinre.2018.01.004_bib0170","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/apt.12771","article-title":"Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy","volume":"39","author":"An","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.clinre.2018.01.004_bib0175","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/lt.24636","article-title":"Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy","volume":"22","author":"Kashani","year":"2016","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.clinre.2018.01.004_bib0180","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2017.05.006","article-title":"Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding","volume":"67","author":"Wang","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2018.01.004_bib0185","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26684","article-title":"Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests","volume":"59","author":"Berlioux","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2018.01.004_bib0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cld.2011.12.008","article-title":"Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt","volume":"16","author":"Riggio","year":"2012","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.clinre.2018.01.004_bib0195","doi-asserted-by":"crossref","first-page":"S1051","DOI":"10.1016\/S0016-5085(16)33549-1","article-title":"815 transjugular intra hepatic porto systemic shunt (TIPS) placement induces modifications of cerebral multimodal MRI in cirrhotic patients, even in the absence of development of hepatic encephalopathy (HE)","volume":"150","author":"Rudler","year":"2016","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.clinre.2018.01.004_bib0200","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.clinre.2018.01.004_bib0205","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/lt.21119","article-title":"Acute liver failure in Spain: analysis of 267 cases","volume":"13","author":"Escorsell","year":"2007","journal-title":"Liver Transpl"},{"issue":"26","key":"10.1016\/j.clinre.2018.01.004_bib0210","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1056\/NEJMra1208937","article-title":"Acute liver failure","volume":"369","author":"Bernal","year":"2013","journal-title":"New Eng J Med"},{"issue":"6","key":"10.1016\/j.clinre.2018.01.004_bib0215","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/hep.21838","article-title":"Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure","volume":"46","author":"Bernal","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2018.01.004_bib0220","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.510290309","article-title":"Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration","volume":"29","author":"Clemmesen","year":"1999","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2018.01.004_bib0225","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/gut.2004.061754","article-title":"Predictive value of arterial ammonia for complications and outcome in acute liver failure","volume":"55","author":"Bhatia","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2018.01.004_bib0230","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(17)30279-9","article-title":"Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure","author":"Cardoso","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2018.01.004_bib0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","article-title":"High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial","volume":"64","author":"Larsen","year":"2016","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2018.01.004_bib0240","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jhep.2015.03.021","article-title":"Pivotal preclinical trial of the spheroid reservoir bioartificial liver","volume":"63","author":"Glorioso","year":"2015","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2018.01.004_bib0245","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy \u2013\u00a0definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.01.004_bib0250","series-title":"Gene Reviews(R)","article-title":"Urea cycle disorders overview","author":"Ah Mew","year":"1993"},{"issue":"4","key":"10.1016\/j.clinre.2018.01.004_bib0255","doi-asserted-by":"crossref","first-page":"e0153358","DOI":"10.1371\/journal.pone.0153358","article-title":"Frequency and pathophysiology of acute liver failure in ornithine transcarbamylase deficiency (OTCD)","volume":"11","author":"Laemmle","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.clinre.2018.01.004_bib0260","article-title":"Peak hyperammonemia and atypical acute liver failure: the eruption of an urea cycle disorder during hyperemesis gravidarum","author":"Weiss","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.clinre.2018.01.004_bib0265","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1021918104127","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"17","author":"Verrotti","year":"2002","journal-title":"Metab Brain Dis"},{"issue":"2","key":"10.1016\/j.clinre.2018.01.004_bib0270","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"47","author":"Lheureux","year":"2009","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"10.1016\/j.clinre.2018.01.004_bib0275","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00280-017-3249-1","article-title":"Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia","volume":"79","author":"Nishikawa","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"10.1016\/j.clinre.2018.01.004_bib0280","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.20905","article-title":"High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study","volume":"42","author":"Riggio","year":"2005","journal-title":"Hepatology"},{"issue":"7\u20138","key":"10.1016\/j.clinre.2018.01.004_bib0285","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1023\/B:DDAS.0000037813.24605.d5","article-title":"Spontaneous intrahepatic portal-systemic venous shunt in the adult: case report and review of the literature","volume":"49","author":"Pocha","year":"2004","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.clinre.2018.01.004_bib0290","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0032-1329896","article-title":"Congenital portosystemic shunts in children: recognition, evaluation and management","volume":"32","author":"Bernard","year":"2012","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.clinre.2018.01.004_bib0295","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1078155214551590","article-title":"Hyperammonemia secondary to asparaginase: a case series","volume":"22","author":"Nussbaum","year":"2016","journal-title":"J Oncol Pharm Pract"},{"issue":"5","key":"10.1016\/j.clinre.2018.01.004_bib0300","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1528-1157.1983.tb03428.x","article-title":"Sodium valproate associated with phenobarbital: effects on ammonia metabolism in humans","volume":"24","author":"Warter","year":"1983","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.clinre.2018.01.004_bib0305","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1592\/phco.28.8.1066","article-title":"Sunitinib-related fulminant hepatic failure: case report and review of the literature","volume":"28","author":"Mueller","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"16","key":"10.1016\/j.clinre.2018.01.004_bib0310","doi-asserted-by":"crossref","first-page":"e6522","DOI":"10.1097\/MD.0000000000006522","article-title":"Unexpected side effect in mCRC: a care-compliant case report of regorafenib-induced hyperammonemic encephalopathy","volume":"96","author":"Quirino","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.clinre.2018.01.004_bib0315","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1750-1172-8-148","article-title":"Long-term neurological outcome of a cohort of 80 patients with classical organic acidurias","volume":"8","author":"Nizon","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.clinre.2018.01.004_bib0320","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000443556","article-title":"Fatty acid beta-oxidation disorders: a brief review","volume":"23","author":"Vishwanath","year":"2016","journal-title":"Ann Neurosci"},{"issue":"8","key":"10.1016\/j.clinre.2018.01.004_bib0325","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/sj.ki.5002790","article-title":"Aminoacidurias: clinical and molecular aspects","volume":"73","author":"Camargo","year":"2008","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.clinre.2018.01.004_bib0330","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ahj.2010.04.013","article-title":"Beyond insurance coverage: usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003\u20132006 National Health and Nutrition Examination Survey","volume":"160","author":"Spatz","year":"2010","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.clinre.2018.01.004_bib0335","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10545-014-9787-3","article-title":"The spectrum of pyruvate oxidation defects in the diagnosis of mitochondrial disorders","volume":"38","author":"Sperl","year":"2015","journal-title":"J inherit Metab dis"},{"issue":"3","key":"10.1016\/j.clinre.2018.01.004_bib0340","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11154-010-9146-0","article-title":"The hyperinsulinism\/hyperammonemia syndrome","volume":"11","author":"Palladino","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"issue":"2\u20133","key":"10.1016\/j.clinre.2018.01.004_bib0345","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s10545-006-0256-5","article-title":"Inborn error of amino acid synthesis: human glutamine synthetase deficiency","volume":"29","author":"Haberle","year":"2006","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"10.1016\/j.clinre.2018.01.004_bib0350","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00415-010-5850-7","article-title":"A urinary cause of coma","volume":"258","author":"Weiss","year":"2011","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.clinre.2018.01.004_bib0355","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0022-5347(17)51414-7","article-title":"Transurethral prostatic resection syndrome \u2013\u00a0a new perspective: encephalopathy with associated hyperammonemia","volume":"130","author":"Hoekstra","year":"1983","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.clinre.2018.01.004_bib0360","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0272-6386(12)80169-7","article-title":"The post-transurethral resection of prostate syndrome: therapeutic proposals","volume":"24","author":"Agarwal","year":"1994","journal-title":"Am J Kidney Dis"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740118300317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740118300317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:27:16Z","timestamp":1761895636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740118300317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2210740118300317"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2018.01.004","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why and when to measure ammonemia in cirrhosis?","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2018.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}